SALADINI FRANCESCO | Elenco docenti

Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Armenia, D., Spagnuolo, V., Bellocchi, M.C., Galli, L., Duca, L., Marchegiani, G., et al. (2024). Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 79(9), 2354-2363 [10.1093/jac/dkae236]. - dettaglio
Biba, C., Fiaschi, L., Varasi, I., Paletti, C., Bartolini, N., Zazzi, M., et al. (2024). A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. VIRUSES, 16(9) [10.3390/v16091465]. - dettaglio
Panza, F., Saladini, F., Bartolini, N., Gianmarino, F., Montagnani, F., Spagnuolo, V., et al. (2024). PRESTIGIO RING “a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests”. NEW MICROBIOLOGICA, 47(1), 116-122. - dettaglio
Mazzitelli, M., Pontillo, D., Clemente, T., Di Biagio, A., Cenderello, G., Rusconi, S., et al. (2024). Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 79(9), 2163-2169 [10.1093/jac/dkae190]. - dettaglio

Tutte le pubblicazioni